Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia.
Oskarsson T, Söderhäll S, Arvidson J, Forestier E, Frandsen TL, Hellebostad M, Lähteenmäki P, Jónsson ÓG, Myrberg IH, Heyman M; Nordic Society of Paediatric Haematology and Oncology (NOPHO) ALL Relapse Working Group. Oskarsson T, et al. Among authors: myrberg ih. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26909. Epub 2017 Dec 12. Pediatr Blood Cancer. 2018. PMID: 29230958 Clinical Trial.
Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Mogensen SS, Harila-Saari A, Mäkitie O, Myrberg IH, Niinimäki R, Vestli A, Hafsteinsdottir S, Griškevicius L, Saks K, Hallböök H, Retpen J, Helt LR, Toft N, Schmiegelow K, Frandsen TL; Nordic Society of Paediatric Haematology and Oncology (NOPHO) group. Mogensen SS, et al. Among authors: myrberg ih. Pediatr Blood Cancer. 2018 Oct;65(10):e27300. doi: 10.1002/pbc.27300. Epub 2018 Jun 26. Pediatr Blood Cancer. 2018. PMID: 29943905
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S, Eriksson MA, Heyman M, Wang C, Niinimäki R, Mikkel S, Vaitkevičienė GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Harila-Saari A, Ranta S. Anastasopoulou S, et al. Among authors: myrberg ih. Pediatr Blood Cancer. 2019 May;66(5):e27594. doi: 10.1002/pbc.27594. Epub 2018 Dec 27. Pediatr Blood Cancer. 2019. PMID: 30592147
Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
Anastasopoulou S, Heyman M, Eriksson MA, Niinimäki R, Taskinen M, Mikkel S, Vaitkeviciene GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Ranta S, Harila-Saari A. Anastasopoulou S, et al. Among authors: myrberg ih. Eur J Paediatr Neurol. 2020 Jul;27:72-77. doi: 10.1016/j.ejpn.2020.04.004. Epub 2020 Apr 18. Eur J Paediatr Neurol. 2020. PMID: 32340855
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S, Nielsen RL, Als-Nielsen B, Banerjee J, Eriksson MA, Helenius M, Heyman MM, Johannsdottir IM, Jonsson OG, MacGregor S, Mateos MK, Mayoh C, Mikkel S, Myrberg IH, Niinimäki R, Schmiegelow K, Taskinen M, Vaitkeviciene G, Warnqvist A, Wolthers B, Harila-Saari A, Ranta S. Anastasopoulou S, et al. Among authors: myrberg ih. Haematologica. 2022 Oct 1;107(10):2318-2328. doi: 10.3324/haematol.2021.280016. Haematologica. 2022. PMID: 35354251 Free PMC article.
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.
Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B, Ng CH, Ravandi F, Andreeff M, Kantarjian HM, Medeiros LJ, Xagoraris I, Khoury JD. Rassidakis GZ, et al. Among authors: myrberg ih. Blood Cancer J. 2018 Oct 19;8(11):98. doi: 10.1038/s41408-018-0134-z. Blood Cancer J. 2018. PMID: 30341277 Free PMC article.
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
Herold N, Rudd SG, Ljungblad L, Sanjiv K, Myrberg IH, Paulin CB, Heshmati Y, Hagenkort A, Kutzner J, Page BD, Calderón-Montaño JM, Loseva O, Jemth AS, Bulli L, Axelsson H, Tesi B, Valerie NC, Höglund A, Bladh J, Wiita E, Sundin M, Uhlin M, Rassidakis G, Heyman M, Tamm KP, Warpman-Berglund U, Walfridsson J, Lehmann S, Grandér D, Lundbäck T, Kogner P, Henter JI, Helleday T, Schaller T. Herold N, et al. Among authors: myrberg ih. Nat Med. 2017 Feb;23(2):256-263. doi: 10.1038/nm.4265. Epub 2017 Jan 9. Nat Med. 2017. PMID: 28067901
15 results